Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2013

Text Block [Abstract]

Schedule of cash dividends declared per common share

Cash dividends declared per common share for the three months ended March 31, 2013 and 2012, were as follows:

	Three months ended March 31,
	2013		2012
Cash dividends declared and paid per common share	$	0.42	$	0.37

Schedule of reconciliation of weighted average number of shares

A reconciliation of these amounts is as follows (in thousands):

	Three months ended March 31,
	2013	2012
Weighted average number of common shares outstanding	68,355	68,177
Director Plan and deferred stock units	340	359
ESOP	98	101
Common shares outstanding—basic	68,793	68,637
Dilutive effect of Option Plans and Omnibus Plan	1,969	2,188
Common and potential common shares outstanding—diluted	70,762	70,825

Schedule of changes in accumulated other comprehensive income (loss) balances

Changes in the accumulated other comprehensive income balance is as follows (in thousands):

	Foreign Currency Items			Cash Flow Hedging Derivatives			Accumulated Other Comprehensive Income
Balance as of December 31, 2012	$	13,669		$	(1,431	)	$	12,238
Reclassification to the income statement	—			(4		)	(4		)
Change in fair value	(1,639		)	1,111			(528		)
Balance as of March 31, 2013	$	12,030		$	(324	)	$	11,706

Schedule of gains and losses, net of tax, reclassified from accumulated other comprehensive income into the income statement for cash flow derivatives designated as hedging instruments

The table below provides data about the amount of gains and losses, net of tax, reclassified from accumulated other comprehensive income into the income statement for cash flow derivatives designated as hedging instruments for the three months ended March 31, 2013 and 2012 (in thousands):

Derivatives in Cash Flow Hedging Relationships	Location of Gain (Loss) Reclassified from Accumulated OCI into Income	Three months ended March 31,
		2013			2012
Foreign currency contracts	Other income, net	$	(220	)	$	(2,006	)
Foreign currency contracts	Cost of sales	216			106
Total		$	(4	)	$	(1,900	)